DTIL
Price
$4.66
Change
-$0.11 (-2.31%)
Updated
Apr 1, 02:32 PM (EDT)
Capitalization
49.27M
RENB
Price
$0.51
Change
-$0.03 (-5.56%)
Updated
Apr 1, 02:54 PM (EDT)
Capitalization
93.99M
Ad is loading...

DTIL vs RENB

Header iconDTIL vs RENB Comparison
Open Charts DTIL vs RENBBanner chart's image
Precision BioSciences
Price$4.66
Change-$0.11 (-2.31%)
Volume$100
Capitalization49.27M
Renovaro
Price$0.51
Change-$0.03 (-5.56%)
Volume$200
Capitalization93.99M
DTIL vs RENB Comparison Chart
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. RENB commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and RENB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (DTIL: $4.77 vs. RENB: $0.54)
Brand notoriety: DTIL and RENB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 68% vs. RENB: 34%
Market capitalization -- DTIL: $49.27M vs. RENB: $93.99M
DTIL [@Biotechnology] is valued at $49.27M. RENB’s [@Biotechnology] market capitalization is $93.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileRENB’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • RENB’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than RENB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 3 TA indicator(s) are bullish while RENB’s TA Score has 4 bullish TA indicator(s).

  • DTIL’s TA Score: 3 bullish, 7 bearish.
  • RENB’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, RENB is a better buy in the short-term than DTIL.

Price Growth

DTIL (@Biotechnology) experienced а -15.43% price change this week, while RENB (@Biotechnology) price change was -24.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.00%. For the same industry, the average monthly price growth was -12.26%, and the average quarterly price growth was -11.16%.

Reported Earning Dates

DTIL is expected to report earnings on May 13, 2024.

RENB is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (-8.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RENB($94M) has a higher market cap than DTIL($49.3M). DTIL YTD gains are higher at: 25.197 vs. RENB (-34.985). DTIL has higher annual earnings (EBITDA): 18.8M vs. RENB (-115.96M). DTIL has more cash in the bank: 101M vs. RENB (312K). RENB has less debt than DTIL: RENB (6.37M) vs DTIL (30.3M). DTIL has higher revenues than RENB: DTIL (75.1M) vs RENB (0).
DTILRENBDTIL / RENB
Capitalization49.3M94M52%
EBITDA18.8M-115.96M-16%
Gain YTD25.197-34.985-72%
P/E Ratio4.55N/A-
Revenue75.1M0-
Total Cash101M312K32,372%
Total Debt30.3M6.37M476%
FUNDAMENTALS RATINGS
DTIL vs RENB: Fundamental Ratings
DTIL
RENB
OUTLOOK RATING
1..100
2158
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4799
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for RENB (98) in the Financial Conglomerates industry. This means that DTIL’s stock grew somewhat faster than RENB’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that DTIL’s stock grew similarly to RENB’s over the last 12 months.

DTIL's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for RENB (99) in the Financial Conglomerates industry. This means that DTIL’s stock grew somewhat faster than RENB’s over the last 12 months.

DTIL's Price Growth Rating (65) in the Biotechnology industry is in the same range as RENB (65) in the Financial Conglomerates industry. This means that DTIL’s stock grew similarly to RENB’s over the last 12 months.

DTIL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that DTIL’s stock grew similarly to RENB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILRENB
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNMBY286.173.69
+1.31%
Rheinmetall AG
JSDA0.21N/A
-0.30%
Jones Soda Co.
TRYIY13.58-0.18
-1.31%
Toray Industries Inc.
OLYMY13.00-0.33
-2.48%
Olympus Corp.
NWBO0.23-0.01
-2.57%
Northwest Biotherapeutics, Inc.

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+1.49%
AXON - DTIL
46%
Loosely correlated
-1.68%
ORMP - DTIL
41%
Loosely correlated
-3.17%
ARRY - DTIL
39%
Loosely correlated
-4.13%
RENB - DTIL
36%
Loosely correlated
-6.15%
COGT - DTIL
35%
Loosely correlated
-7.56%
More

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-6.15%
VRCA - RENB
37%
Loosely correlated
+2.12%
DTIL - RENB
36%
Loosely correlated
+1.49%
TNGX - RENB
34%
Loosely correlated
-6.80%
AAVXF - RENB
26%
Poorly correlated
N/A
QSI - RENB
26%
Poorly correlated
-5.51%
More